Главная › Рак мочевого пузыря › Нью-Йорк › New York City
Клинические исследования Рак мочевого пузыря в городе New York City, NY
35 исследований по теме Рак мочевого пузыря ищут участников в центрах в городе New York City и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Набор участниковФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Набор участниковФаза 3
- Veterans Affairs New York Harbor Healthcare System-Manhattan Campus, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набор участниковФаза 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- и еще 2
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Набор участниковФаза 1/2
- Memorial Sloan Kettering Cancer Center ( Site 5031), New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 2
- Memorial Sloan Kettering Hospital, New York
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Набор участниковФаза 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Набор участниковФаза 2
- NYP/Weill Cornell Medical Center, New York
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Набор участниковФаза 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Набор участниковФаза 1/2
- Icahn School of Medicine at Mount Sinai, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Набор участниковФаза 1
- Columbia University Irving Medical Center, New York
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Набор участниковФаза 1
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street, New York
- Icahn School of Medicine at Mount Sinai, New York
- и еще 3
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Набор участниковФаза 3
- Memorial Sloan Kettering Cancer Center ( Site 0832), New York
A Study of Surgical Techniques During Cystectomy
Набор участниковФаза 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Набор участниковФаза 3
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Набор участниковФаза 1
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Набор участниковФаза 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Набор участниковФаза 2
- Integrated Medical Professionals, PLLC (Solaris), New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Набор участников
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Набор участниковФаза 2
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Набор участниковФаза 1
- New York University (NYU), New York
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- и еще 2
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Набор участниковФаза 3
- Memorial Sloan Kettering Cancer Center, New York
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Набор участников
- City College of New York (Data Collection AND Specimen Analysis), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Набор участниковФаза 2/3
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Набор участниковФаза 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Набор участниковФаза 2
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Icahn School of Medicine at Mount Sinai, New York
- Evelyn H. Lauder Breast and Imaging Centre (BAIC), New York
- и еще 2
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Набор участниковФаза 3
- Research Site, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Набор участниковФаза 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Набор участников
- Integrated Medical Professionals, New York
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Набор участниковФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набор участниковФаза 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Blue Light Cystoscopy With Cysview® Registry
Набор участниковНаблюдательное исследование
- NYU Langone's Perlmutter Cancer Center, New York
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
Набор участников
- Mount Sinai Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, New York
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
Набор участниковФаза 2
- Columbia University Irving Medical Center/ New York Presbyterian Hospital, New York
Исследования Рак мочевого пузыря в других городах
- Nashville, TN31 исследование
- Houston, TX31 исследование
- Dallas, TX27 исследований
- Washington, DC26 исследований
- Boston, MA26 исследований
- Baltimore, MD24 исследований
- Los Angeles, CA24 исследований
- St. Louis, MO22 исследований
- Seattle, WA21 исследование
- Philadelphia, PA21 исследование
- Chicago, IL21 исследование
- Edison, NJ21 исследование
Другие исследования в городе New York City
- Рак молочной железы136 исследований
- Немелкоклеточный рак легкого121 исследование
- Рак (все виды)109 исследований
- Рак простаты103 исследований
- Метастатический рак93 исследований
- Колоректальный рак78 исследований
- Рак яичников69 исследований
- Рак легких60 исследований
- Множественная миелома60 исследований
- Рак поджелудочной железы60 исследований
- Рак эндометрия52 исследований
- Острый миелоидный лейкоз51 исследование
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.